Profile: Grifols SA (GRLS.MC)

GRLS.MC on Madrid SE C.A.T.S.

33.21EUR
19 Dec 2014
Price Change (% chg)

€0.58 (+1.79%)
Prev Close
€32.62
Open
€32.88
Day's High
€33.64
Day's Low
€32.50
Volume
1,542,230
Avg. Vol
915,339
52-wk High
€42.53
52-wk Low
€27.91

Search Stocks
Grifols SA is a Spain-based company engaged in the healthcare sector. The Company is involved in the research, development, manufacturing and marketing of medical solutions for hospitals, which include plasma-derived therapies, as well as diagnosis and pharmaceutical products. Its activities are structured in five segments: Bioscience, which focuses on the research for obtaining new therapies and solutions aimed at patients who suffer from illnesses stemming from plasma deficits; Diagnostic, which comprises the research, development and marketing of diagnostic products for clinical laboratories, Hospital, which offers ready-to-use pharmaceutical preparations and products for clinical nutrition; Technology, which focuses on automation equipment for the hospital sector; and Raw Materials, which includes sales of biological products and services. The Company is a parent of Grupo Grifols.

Company Address

Grifols SA

C/ Jesus i Maria, 6
BARCELONA   BAR   08022
P: +34935.710100
F: +34935.710267

Search Stocks